Overview
Fumitaka Okajima practices in Chiba, Japan. Okajima is rated as a Distinguished expert by MediFind in the treatment of Hyperlipoproteinemia Type 5. Their top areas of expertise are Hyperlipoproteinemia Type 5, Graves Disease, Hyperthyroidism, and Familial Hypertriglyceridemia.
Their clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hyperlipoproteinemia Type 5.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hyperlipoproteinemia Type 5Okajima isDistinguished. Learn about Hyperlipoproteinemia Type 5.
- Experienced
- Achilles Tendon RuptureOkajima isExperienced. Learn about Achilles Tendon Rupture.
- Acute Coronary SyndromeOkajima isExperienced. Learn about Acute Coronary Syndrome.
- Defective Apolipoprotein B-100Okajima isExperienced. Learn about Defective Apolipoprotein B-100.
- Diabetic NephropathyOkajima isExperienced. Learn about Diabetic Nephropathy.
- Familial HypercholesterolemiaOkajima isExperienced. Learn about Familial Hypercholesterolemia.
- Familial HypertriglyceridemiaOkajima isExperienced. Learn about Familial Hypertriglyceridemia.